Hydrix expands engineering engagement with Quantanosis AI
Hydrix announced an expanded engagement on Quantanosis AI’s robotic stroke-treatment platform combining robotics, AI and histotripsy.
Evidence notes
- Hydrix expanded its engineering engagement on Quantanosis AI’s robotic stroke-treatment platform combining robotics, AI and histotripsy.
- The work follows initial simulation and modelling of the treatment system.
- Development support now extends to the next-generation robotic treatment platform.
Company context
Hydrix is an Australian engineering and product-development company with a defence payload role in counter-UAS work. Its current robotics relevance comes from development and integration of telemetry-capable inert proximity fuze and kinetic effector payloads for small UAS missions.